Methylprednisolone Not Yet Recruiting Phase 2 Trials for Immune Thrombocytopenia Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02757196Treatment of ITP With Rituximab and / or Accutane